DNTH Dianthus Therapeutics, Inc.
$104.74▼ -2.74%
Healthcare
Other
Volume 145.9K
Avg Volume (10D) 618.1K
Key Metrics & Fundamentals
Market Cap
$5.86B
P/E Ratio
–
Div Yield
–%
52W Range
32.22 - 117.88
% vs 50 MA
1.17%
% vs 200 MA
38.74%
RSI-14
50.2
MACD Histogram
-0.6300
Beta (1Y vs SPY)
0.89
Free Cash Flow
-$49.16M
Gross Rev
$761,000
Gross Profit
$761,000
EBITDA
-$61.47M
COGS
–
Operating Exp
$62.24M
Operating Income
-$61.48M
EBIT
-$61.48M
Pretax Income
-$50.22M
Net Income
-$50.22M
EPS (Diluted)
-0.90
Price & Volume History
Loading chart…
Recent News
JPMorgan Initiates Coverage on Dianthus Therapeutics With Overweight Rating
MT Newswires · Sep 11, 2026 11:14 AM
Dianthus (DNTH) Piles Up Clinical Wins While Its Losses Widen
Insider Monkey · Sep 5, 2026 11:30 AM
UiPath downgraded, Shell upgraded: Wall Street's top analyst calls
The Fly · Sep 4, 2026 1:48 PM
Citigroup Initiates Dianthus Therapeutics at Buy With $156 Price Target
MT Newswires · Sep 4, 2026 9:52 AM
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 2, 2026 9:00 PM
Dianthus Therapeutics to Participate in Three Investor Conferences During September
GlobeNewswire · Sep 1, 2026 12:00 PM
Dianthus Therapeutics Insider Sold Shares Worth $844,822, According to a Recent SEC Filing
MT Newswires · Aug 11, 2026 9:24 PM
Dianthus Therapeutics Insider Sold Shares Worth $2,208,833, According to a Recent SEC Filing
MT Newswires · Aug 11, 2026 9:12 PM
Wedbush Adjusts Price Target on Dianthus Therapeutics to $122 From $105, Maintains Outperform Rating
MT Newswires · Aug 5, 2026 11:47 AM
Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 4, 2026 9:40 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See DNTH's money flow as a full page
Social Sentiment
No Reddit posts found for DNTH.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.